Home › Trials › NCT06117709
Clinical trial Recruiting at 1 site Interventional Ages 21 and up

Integrated Smartphone Tool to Help Manage Malignant Pain

Official title: Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP): Development, Usability, and Acceptability Testing

Run by Dana-Farber Cancer Institute · NCT06117709 · Data updated 2026-11-12

A smartphone app called I-STAMP is being tested to help adults with advanced cancer see if it can better manage their pain and track their medications.

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment73 (estimated)
SponsorDana-Farber Cancer Institute
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedSeptember 18, 2026
Main results expectedDecember 30, 2026
Study endsApril 30, 2027
Registry record updatedOctober 13, 2026
Trial IDNCT06117709 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 21 years or older with current or prior advanced cancer and a history of cancer-related pain who can read and understand English.

Probably not a fit

Individuals unable to understand English or with conditions that prevent completing study procedures may not benefit from the app.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study develops and tests I-STAMP, an electronic health record–integrated mobile health app intended to support pain management for patients with advanced cancer and their care teams. The project includes initial non-interventional activities to gather data, followed by a future amendment to add an interventional component. Up to 73 participants will be enrolled, with eligibility restricted to adults able to understand English and without impairments that would hinder study procedures. Recruitment is centered at Dana-Farber Cancer Institute in Boston, MA, under the lead sponsorship of Dana-Farber without additional collaborators at this time.

Why it matters

Potential benefit: If successful, the app could help patients better monitor pain and medications and improve communication with their care team.

How similar studies have gone: Previous work with mobile health tools for cancer pain has shown potential benefits, though this study's integrated EHR approach is moderately novel for this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria for Participants (Activities 1a, 2a, 3a):

* Age ≥ 21 years
* Current or previous diagnosis of advanced cancer
* Current or previous experience with cancer pain

Exclusion Criteria for Participants (Activities 1a, 2a, 3a):

* Inability to understand, speak, or read English
* Any condition that would impede the patient's ability to complete study procedures such as visual impairment or significant cognitive impairment as determined by the participant's treating provider.

Where it's running

  • Dana Farber Cancer Institute
    Boston, Massachusetts, United States     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Advanced Cancer 146Dana-Farber Cancer Institute 150
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.